Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation IRVINE, Calif. — (June 21, 2018) — Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, has embarked on a strategic collaboration with the University of California, Irvine – one of the first targeted academic partnerships the company envisions... Read more
BREA, Calif., June 19, 2018 /PRNewswire/ — Beckman Coulter announced today the positive results of a clinical trial suggesting that blood tests may offer key benefits in the initial screening for obstructive sleep apnea. The study, which involved 264 male adult patients from six institutions, revealed that screening for changes in three specific biomarkers may be... Read more
BREA, Calif., May 1, 2018 /PRNewswire/ — Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to perform complete blood count and white blood cell differential tests with minimal repeats. The DxH 900 is now available for sale in Europe, the United States, Canada, Australia... Read more
Single Chemistry System Extracts Total Nucleic Acid, DNA and/or RNA From Single FFPE Tissue Sample INDIANAPOLIS, IND. (January 18, 2018) – Today, Beckman Coulter Life Sciences launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues. FormaPure reagent kits represent a single chemistry system designed and optimized for... Read more
New assay enables hospitals to provide efficiency improvements in cardiac patient management BREA, CALIF. — (Nov 7, 2017) — Beckman Coulter Diagnostics announced today that it has received CE Mark clearance for a new high-sensitivity troponin (hsTnI) assay that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms. “The new,... Read more
Built upon a 20 year legacy of reliable and efficient performance, the Access 2 delivers new features that advance end-user experience and productivity. BREA, Calif., Aug. 10, 2017 /PRNewswire/ — Beckman Coulter Diagnostics is pleased to announce worldwide availability of the Access 2 immunoassay system with enhanced features. Built upon a 20-year legacy of reliable and efficient performance, the Access... Read more
Clinical Flow Cytometry Innovation Highlighted on Booth #3117, AACC 2017 SAN DIEGO, CALIF. ─ (July 31, 2017) ─ Beckman Coulter Life Sciences features its pioneering in vitro diagnostic ClearLLab reagents at the 69th American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Laboratory Expo (CLE), being held July 31 – August 3, 2017 in... Read more
Workflow-Efficient Navios EX Flow Cytometer for Immunophenotyping in the Clinical Lab SAN DIEGO, CALIF. – (July 31, 2017) – Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest clinical flow cytometry product, the Navios EX flow cytometer, to be used in the clinical laboratory in the... Read more
Menu to include Procalcitonin (PCT)Beckman Coulter Sample Press Release Automated chemistry assay offers a tool for the diagnosis and management of life-threatening bacterial sepsis BREA, CALIF. — (April 20, 2017) — Beckman Coulter Diagnostics announced a partnership with Diazyme Laboratories that allows customers access to a procalcitonin (PCT) assay, an important marker for the detection... Read more
New system helps meet increasing demands for larger test volumes and reduces total cost of ownership for hospital laboratories and integrated delivery networks BREA, Calif., March 7, 2017 /PRNewswire/ — Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities... Read more